Combined immunocell therapy using activated lymphocytes and monocyte-derived dendritic cells for malignant melanoma. Nov 2005 - Anticancer Res.; 25(6A):0250-7005 [PMID:16302734] [Goto S] [Kaneko T] [Miyamoto Y] [Eriguchi M] [Kato A] [Akeyama T] [Fujimoto K] [Tomonaga M] [Egawa K]
